Understanding Evidence-Based Practice Patterns in Advanced NSCLC

NCT03107156 | Completed

• 1 other identifier: G409
• Study Type: interventional
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

The overarching objective of this study is to close clinical knowledge and performance gaps by providing oncology clinicians with the latest advances and emerging research in the evidence-base and personalized treatment of advanced NSCLC patients. In addition, the research team seeks to meet quality measures relevant to value-based care delivery through IT infrastructure and clinical workflow processes. The research team also hopes to gain insights on clinician practice patterns related to advanced NSCLC, and the correlation between advanced NSCLC patients reported goals of care and advanced NSCLC patients' fit/frailty status and treatment decisions.

Conditions

Non Small Cell Lung Cancer

Keywords

Treatment care planning

Outcome Measures

Primary Outcomes (1)

• Adherence (by providers) to evidence-based treatment recommendations for patients with advanced NSCLC

  Data collected on the Carevive CPS will be analyzed in order to correlate the patient biomarker testing results with treatment selections.

  Year 1

Secondary Outcomes (2)

• Components of value-based NSCLC cancer care.

  Year 1

• Clinical practice patterns in medical oncologists managing older patients with advanced NSCLC.

  Year 1

Other Outcomes (1)

• ER utilization and hospitalization in elderly patients with lung cancer

  Year 1

Interventions

Carevive CPS BEHAVIORAL

This intervention will focus on the use of the Carevive CPS at the point of treatment decision making, enabling providers to deliver evidence-based and personalized treatment care plans to their NSCLC patients on active treatment. The Carevive CPS collects electronic patient reported outcomes (ePROS) and clinical data, reported and generated by clinical staff and/or extracted from the electronic medical record (EMR), and uses these to auto-generate the personalized care plans. Care plan content is drive by practice guidelines and other peer-reviewed evidence, and includes patient education, resources, and referrals developed by cancer clinicians and researchers.

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• years of age or older
• Diagnosis of NSCLC
• Newly diagnosed, in need of a new line or therapy, or at a treatment decision making timepoint.
• Must be able to understand English

You may not qualify if:

• Any patient who cannot understand written or spoken English
• Any prisoner and.or other vulnerable person

Sponsors & Collaborators

• Carevive Systems, Inc.: lead

Study Sites (1)

Jefferson University

Philadelphia, Pennsylvania, 19107, United States

Location

MeSH Terms

Conditions

Carcinoma, Non-Small-Cell Lung

Condition Hierarchy (Ancestors)

Carcinoma, Bronchogenic; Bronchial Neoplasms; Lung Neoplasms; Respiratory Tract Neoplasms; Thoracic Neoplasms; Neoplasms by Site; Neoplasms; Lung Diseases; Respiratory Tract Diseases

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: SINGLE GROUP
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 30, 2017
• First Posted: April 11, 2017
• Study Start: January 1, 2018
• Primary Completion: December 31, 2018
• Study Completion: April 30, 2019
• Last Updated: August 28, 2019

Record last verified: 2019-08

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)